Resilience Relocates West Coast HQ to Ohio, Expands Sterile Manufacturing

Event summary

  • Resilience relocates its corporate headquarters from San Diego, California to Blue Ash, Ohio.
  • The move strengthens Resilience's operational footprint in Ohio, reinforcing the state's position as a growing hub for pharmaceutical and sterile manufacturing innovation.
  • Resilience's Blue Ash site will serve as a world-class drug product packaging and supply operation spanning more than 450,000 square feet.
  • The company anticipates adding approximately 200 new jobs in Blue Ash.
  • Resilience announced its investment in a Groninger multi-purpose injectable fill/finish line at its West Chester, Ohio facility.

The big picture

Resilience's move to Ohio aligns with a broader trend of biopharmaceutical companies relocating to states with lower taxes, less regulatory burden, and a skilled workforce. This strategic shift underscores the growing importance of domestic manufacturing in the pharmaceutical industry, particularly for sterile injectables and complex medicines. The expansion of Resilience's capabilities in Ohio positions the company to better support the evolving needs of the biopharmaceutical sector and strengthen the U.S. healthcare supply chain.

What we're watching

Regional Shift
How Resilience's relocation will impact its operational efficiency and access to talent in Ohio compared to California.
Manufacturing Capacity
Whether the expansion of sterile manufacturing capabilities will meet the growing demand for complex medicines.
Economic Impact
The pace at which Resilience's investment will drive economic growth and job creation in the Blue Ash region.

Related topics

Expansion